News for Salarius Pharmaceuticals, Inc. (SLRX)

Decoy Therapeutics has announced a key addition to its Scientific Advisory Board, heralding a new chapter as it prepares to merge with Salarius Pharmaceuticals

**media[577165]**

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of novel peptide

Salarius Pharmaceuticals (SLRX) reports FY GAAP EPS of -$5.79. Cash reserves at $2.4M, projected to support operations until late Q2 2025.

Utah-based Sintx Technologies, Inc. (SINT) is up over 87 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

HOUSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. ( SLRX) announces that patient enrollment will resume in the investigator-initiated

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.85%

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 150 points on Monday. The Dow traded up 0.64% to 42,206.46 while t...

Salarius Pharmaceuticals and Decoy Therapeutics announce merger agreement, creating new company led by current leadership teams.

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded up 0.13% to 41,992.95 while the NA...

U.S. stocks traded mixed this morning, with the Nasdaq Composite falling over 1% on Monday. The Dow traded up 0.26% to 42,049.01 while the NASDAQ dipped 1.24% ...

Decoy's proprietary IMP3ACTâ„¢ peptide conjugate drug design and manufacturing platform leverages machine learning (ML) and artificial intelligence (AI) tools

SLRX stock touches 52-week low at $1.24 amid market challenges

Allovir, Inc. (ALVR) has witnessed a notable stock price decline of 5.16%. The stock is currently priced at $0.810 per share, with a trading volume of 63,122 sh

Adagene Inc. (ADAG), a clinical-stage biopharmaceutical company, experienced a significant stock movement with a 5.43% surge in its share price. The stock is cu

Shares of Edwards Lifesciences Corporation EW fell sharply during Thursday's session after the company reported worse-than-expected second-quarter sales results...

Loading... Loading... Shares of CrowdStrike Holdings, Inc. CRWD fell sharply during Monday’s session. Guggenheim analyst John Difucci downgraded the stock fr...

Loading... Loading... Shares of Tellurian Inc. TELL rose sharply in today's pre-market trading after Woodside Energy announced plans to acquire the company for...

Loading... Loading... Shares of Selective Insurance Group, Inc. SIGI fell sharply during Friday's session following weak quarterly results. Selective Insuranc...